FDA Warning Letters: Oct. 14
This article was originally published in The Gray Sheet
Executive Summary
FDA posted three device warning letters on Oct. 14, including one to Zoll's Lifecor division, which makes the LifeVest wearable defibrillator, for quality systems and adverse-event reporting violations.